<?xml version="1.0" encoding="UTF-8"?>
<fig id="F3" orientation="portrait" position="float">
 <label>Figure 3.</label>
 <caption>
  <p>Real occurring drug–drug interactions between outpatient medications and hepatitis C virus (HCV) regimens for each patient at baseline. A, Jan 2014–Nov 2014. B, Nov 2014–Aug 2016. C, Aug 2016–Jul 2018. D, Real occurring drug–drug interactions between outpatient medications and HCV regimens for each patient at baseline depending on the presence of cirrhosis and age. E, Real occurring drug–drug interactions between outpatient medications and HCV regimens for patients taking ≥8 drugs outpatient medications at baseline. Green: no interaction expected; yellow: potential weak interaction; orange: potential significant interaction; red: do not coadminister.</p>
 </caption>
 <graphic xlink:href="ofaa040f0003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
